
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2023-12-21 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2023-12-05 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2023-07-10 | Daniel Goldman(D-NY10) | house | Sale | $15,001 - $50,000 |
| 2021-04-13 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
No financial data available for LZAGY.
Company may not file with SEC or CIK is unresolved.
Analysis of the 2026 Oral Solid Dosage Contract Manufacturing Market - Scalable Pharma Solutions & Generic Demand Drive $59.05 Billion Forecast for 2030
Artisan Global Opportunities Fund Q1 2026 Portfolio Activity
[Latest] Global Cell Culture Media Bags Market Size/Share Worth USD 2.28 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Is Lonza Group (SWX:LONN) Pricing Too High After Recent Share Price Swings?
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
Small Molecule Innovator API CDMO Market Outlook, 2026-2033 - Lonza Group, Novo Holdings (Catalent) and Thermo Fisher Scientific Lead the Growing Industry
Lonza: Structural Growth Intact, CHI Exit Strengthens Focus, Recent Weakness Reinforces Entry Opportunity
Most oversold healthcare stocks above $10B on Wall Street amid Middle East disruptions
[Latest] Global Viral Vaccine Cell Culture Media Market Size/Share Worth USD 3.5 Billion by 2035 at a 6.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Lonza Group AG (LZAGY) Discusses Divestment of Capsules and Health Ingredients Business and Focus on CDMO Transformation Transcript
Lonza Group AG (LZAGY) Discusses Divestment of Capsules and Health Ingredients Business and Focus on CDMO Transformation - Slideshow
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG